{"id":54852,"date":"2026-01-20T19:16:52","date_gmt":"2026-01-20T11:16:52","guid":{"rendered":"https:\/\/flcube.com\/?p=54852"},"modified":"2026-01-20T19:16:53","modified_gmt":"2026-01-20T11:16:53","slug":"easydiagnosis-bio-to-acquire-51-of-ailex-medical-in-5-1m-deal-gains-ivd-platform","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=54852","title":{"rendered":"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform"},"content":{"rendered":"\n<p><strong>Wuhan EasyDiagnosis Biomedicine Co., Ltd<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/002932:SHE\">SHE: 002932<\/a>) announced plans to acquire a <strong>51% stake<\/strong> in <strong>Ailex (Hunan) Medical Device Co., Ltd<\/strong> for <strong>RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion)<\/strong>, gaining control of an <strong>IVD instrument and reagent platform<\/strong> specializing in <strong>glycated hemoglobin detection<\/strong> and securing a pathway to full ownership by 2028.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-transaction-overview\">Transaction Overview<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Acquirer<\/strong><\/td><td>Wuhan EasyDiagnosis Biomedicine (002932.SZ)<\/td><\/tr><tr><td><strong>Target<\/strong><\/td><td>Ailex (Hunan) Medical Device Co., Ltd<\/td><\/tr><tr><td>**Initial Stake<\/td><td>51%<\/td><\/tr><tr><td>**Consideration<\/td><td>RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion)<\/td><\/tr><tr><td>**Status<\/td><td>Controlled subsidiary (consolidated financials)<\/td><\/tr><tr><td>**Second\u2011Phase Option<\/td><td>49% contingent on performance (2026\u20112028)<\/td><\/tr><tr><td>**Full Ownership<\/td><td>100% upon completion<\/td><\/tr><tr><td>**Expected Close<\/td><td>Q1\u202f2026<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-target-profile-amp-strategic-rationale\">Target Profile &amp; Strategic Rationale<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**Business Focus | R&amp;D, production, and services for *<em>IVD instruments and reagents<\/em>*<\/li>\n\n\n\n<li>**Recognition | *<em>National High\u2011Tech Enterprise<\/em>* and <strong>&#8220;Little Giant&#8221;<\/strong> company status<\/li>\n\n\n\n<li>**Core Technology | Localization of *<em>glycated hemoglobin detection<\/em>* products<\/li>\n\n\n\n<li>**Current Status | *<em>Unprofitable<\/em>* but with established product pipeline and manufacturing<\/li>\n\n\n\n<li>**Strategic Fit | Expands EasyDiagnosis\u2019s *<em>IVD portfolio<\/em>* and <strong>localizes supply chain<\/strong> for diabetes diagnostics<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-financial-terms-amp-performance-metrics\">Financial Terms &amp; Performance Metrics<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Phase<\/th><th>Stake<\/th><th>Condition<\/th><th>Timeline<\/th><\/tr><\/thead><tbody><tr><td>**Initial<\/td><td>51%<\/td><td>RMB\u202f35.7\u202fmillion upfront<\/td><td>Q1\u202f2026<\/td><\/tr><tr><td>**Second\u2011Phase<\/td><td>49%<\/td><td>Average annual net profit <strong>\u2265 RMB\u202f20\u202fmillion (USD\u202f2.9\u202fM)<\/strong><\/td><td>2026\u20112028<\/td><\/tr><tr><td>**Failure to Meet Target<\/td><td>Renegotiation of acquisition terms<\/td><td>\u2013<\/td><td><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Performance Threshold:<\/strong> RMB\u202f20\u202fmillion annual net profit over three years represents <strong>turnaround requirement<\/strong> for unprofitable target<\/li>\n\n\n\n<li><strong>Risk Mitigation:<\/strong> Renegotiation clause protects EasyDiagnosis if Ailex fails to achieve profitability<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-impact-amp-consolidation\">Market Impact &amp; Consolidation<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li>**IVD Market Size | China IVD market valued at *<em>\u00a5120\u202fbillion (2026E)<\/em>*, growing at *<em>12% CAGR<\/em>*<\/li>\n\n\n\n<li>**Diabetes Diagnostics | Glycated hemoglobin testing market worth *<em>\u00a518\u202fbillion<\/em>* with <strong>localization push<\/strong> from regulators<\/li>\n\n\n\n<li>**Synergies | EasyDiagnosis\u2019s *<em>distribution network<\/em>* (3,000 hospitals) can rapidly commercialize Ailex\u2019s products<\/li>\n\n\n\n<li>**Manufacturing | Ailex\u2019s *<em>Changsha facility<\/em>* adds <strong>2,000\u202fsqm<\/strong> of production capacity for reagent kits<\/li>\n<\/ul>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding acquisition completion, performance targets, and market synergies. Actual results may differ due to regulatory approvals, integration challenges, and Ailex\u2019s ability to achieve profitability.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/\u660e\u5fb7\u751f\u7269\uff1a\u5173\u4e8e\u589e\u8d44\u5e76\u6536\u8d2d\u84dd\u6021\uff08\u6e56\u5357\uff09\u533b\u7597\u5668\u68b0\u6709\u9650\u516c\u53f8\u80a1\u6743\u7684\u516c\u544a.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"Embed of \u660e\u5fb7\u751f\u7269\uff1a\u5173\u4e8e\u589e\u8d44\u5e76\u6536\u8d2d\u84dd\u6021\uff08\u6e56\u5357\uff09\u533b\u7597\u5668\u68b0\u6709\u9650\u516c\u53f8\u80a1\u6743\u7684\u516c\u544a.\"><\/object><a id=\"wp-block-file--media-83d8da5c-5249-4191-b4d7-878677c7656d\" href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/\u660e\u5fb7\u751f\u7269\uff1a\u5173\u4e8e\u589e\u8d44\u5e76\u6536\u8d2d\u84dd\u6021\uff08\u6e56\u5357\uff09\u533b\u7597\u5668\u68b0\u6709\u9650\u516c\u53f8\u80a1\u6743\u7684\u516c\u544a.pdf\">\u660e\u5fb7\u751f\u7269\uff1a\u5173\u4e8e\u589e\u8d44\u5e76\u6536\u8d2d\u84dd\u6021\uff08\u6e56\u5357\uff09\u533b\u7597\u5668\u68b0\u6709\u9650\u516c\u53f8\u80a1\u6743\u7684\u516c\u544a<\/a><a href=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/01\/\u660e\u5fb7\u751f\u7269\uff1a\u5173\u4e8e\u589e\u8d44\u5e76\u6536\u8d2d\u84dd\u6021\uff08\u6e56\u5357\uff09\u533b\u7597\u5668\u68b0\u6709\u9650\u516c\u53f8\u80a1\u6743\u7684\u516c\u544a.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-83d8da5c-5249-4191-b4d7-878677c7656d\">Download<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10,22],"tags":[4563,1653,1654],"class_list":["post-54852","post","type-post","status-publish","format-standard","hentry","category-company","category-deals","category-medical-device","tag-ailex-medical-device","tag-easydiagnosis-biomedicine","tag-she-002932"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in Ailex (Hunan) Medical Device Co., Ltd for RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion), gaining control of an IVD instrument and reagent platform specializing in glycated hemoglobin detection and securing a pathway to full ownership by 2028.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=54852\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform\" \/>\n<meta property=\"og:description\" content=\"Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in Ailex (Hunan) Medical Device Co., Ltd for RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion), gaining control of an IVD instrument and reagent platform specializing in glycated hemoglobin detection and securing a pathway to full ownership by 2028.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=54852\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-20T11:16:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-20T11:16:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54852#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54852\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform\",\"datePublished\":\"2026-01-20T11:16:52+00:00\",\"dateModified\":\"2026-01-20T11:16:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54852\"},\"wordCount\":314,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Ailex Medical Device\",\"EasyDiagnosis Biomedicine\",\"SHE: 002932\"],\"articleSection\":[\"Company\",\"Deals\",\"Medical Device\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54852#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54852\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=54852\",\"name\":\"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-01-20T11:16:52+00:00\",\"dateModified\":\"2026-01-20T11:16:53+00:00\",\"description\":\"Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in Ailex (Hunan) Medical Device Co., Ltd for RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion), gaining control of an IVD instrument and reagent platform specializing in glycated hemoglobin detection and securing a pathway to full ownership by 2028.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54852#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=54852\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=54852#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform - Insight, China&#039;s Pharmaceutical Industry","description":"Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in Ailex (Hunan) Medical Device Co., Ltd for RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion), gaining control of an IVD instrument and reagent platform specializing in glycated hemoglobin detection and securing a pathway to full ownership by 2028.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=54852","og_locale":"en_US","og_type":"article","og_title":"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform","og_description":"Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in Ailex (Hunan) Medical Device Co., Ltd for RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion), gaining control of an IVD instrument and reagent platform specializing in glycated hemoglobin detection and securing a pathway to full ownership by 2028.","og_url":"https:\/\/flcube.com\/?p=54852","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-01-20T11:16:52+00:00","article_modified_time":"2026-01-20T11:16:53+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=54852#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=54852"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform","datePublished":"2026-01-20T11:16:52+00:00","dateModified":"2026-01-20T11:16:53+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=54852"},"wordCount":314,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Ailex Medical Device","EasyDiagnosis Biomedicine","SHE: 002932"],"articleSection":["Company","Deals","Medical Device"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=54852#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=54852","url":"https:\/\/flcube.com\/?p=54852","name":"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-01-20T11:16:52+00:00","dateModified":"2026-01-20T11:16:53+00:00","description":"Wuhan EasyDiagnosis Biomedicine Co., Ltd (SHE: 002932) announced plans to acquire a 51% stake in Ailex (Hunan) Medical Device Co., Ltd for RMB\u202f35.7\u202fmillion (USD\u202f5.1\u202fmillion), gaining control of an IVD instrument and reagent platform specializing in glycated hemoglobin detection and securing a pathway to full ownership by 2028.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=54852#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=54852"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=54852#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"EasyDiagnosis Bio to Acquire 51% of Ailex Medical in $5.1M Deal, Gains IVD Platform"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54852","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=54852"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54852\/revisions"}],"predecessor-version":[{"id":54855,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/54852\/revisions\/54855"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=54852"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=54852"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=54852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}